Kate M Crossley Shruti Agnihotri Joga Chaganti Michael L Rodriguez Leon Patrick McNally Nagagopal Venna Sarah E Turbett Matthew Gutman Adrienne Morey Igor J Koralnik Bruce J Brew
10.1007/s13365-015-0419-y
J Neurovirol
2016 Aug;22(4):541-5.
neuroimmunology neurovirology progressive multifocal leukoencephalopathy
CC BY
https://pubmed.ncbi.nlm.nih.gov/26727910/
Anti-HIV Agents / therapeutic use HIV Infections / virology Leukoencephalopathy, Progressive Multifocal / virology Natalizumab / therapeutic use
Anti-HIV Agents / therapeutic use HIV Infections / virology Leukoencephalopathy, Progressive Multifocal / virology Natalizumab / therapeutic use Case Reports Antiretroviral Therapy, Highly Active CD4 Lymphocyte Count CD4-Positive T-Lymphocytes / immunology CD4-Positive T-Lymphocytes / virology Coinfection Female HIV Infections / diagnosis HIV Infections / drug therapy HIV Infections / immunology HIV-1 / immunology HIV-1 / pathogenicity Humans JC Virus / immunology JC Virus / pathogenicity Leukoencephalopathy, Progressive Multifocal / diagnosis Leukoencephalopathy, Progressive Multifocal / drug therapy Leukoencephalopathy, Progressive Multifocal / immunology Male Middle Aged Recurrence Anti-HIV Agents Natalizumab
PMC4925684
26727910
Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals
2016